Physician
Pullukat, Annamma
Pullukat, Annamma was paid $3.13M by Medicaid between Jan 2018 and Aug 2023, across 55 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoPULLUKAT, ANNAMMA
PONTIAC, MI 48341
PONTIAC, MI 48341
33aNPI1952419400assigned 08/25/2006
33bProvider typePediatrics Physician
28Total paid$3.13M
24GClaims137,999
24DCodes billed55
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Pediatrics Physician providers in Michigan
Rank by total paid#43 of 349
Median peer was paid$321K
This provider vs. median9.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,529 | $532K | |
| 2019 | 24,094 | $493K | |
| 2020 | 16,522 | $368K | |
| 2021 | 26,847 | $679K | |
| 2022 | 29,170 | $965K | |
| 2023 | 2,837 | $97K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 23,777 | 18,607 | $1.23M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 6,794 | 5,825 | $428K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 10% | 5,427 | 4,501 | $328K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.9% | 4,411 | 3,724 | $247K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.7% | 2,714 | 2,199 | $177K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.4% | 4,374 | 3,848 | $137K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.3% | 7,512 | 6,479 | $104K |
| 99381 | 2.7% | 1,084 | 998 | $85K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.5% | 11,353 | 9,755 | $78K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.9% | 609 | 591 | $58K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.3% | 1,237 | 1,223 | $42K |
| 99383 | <1% | 332 | 332 | $30K |
43 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,502 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,310 | $28K |
| 85018 | <1% | 14,075 | $24K | |
| 99382 | <1% | 236 | $21K | |
| 83655 | <1% | 2,022 | $19K | |
| 96127 | <1% | 5,043 | $14K | |
| 99384 | <1% | 140 | $14K | |
| 81002 | <1% | 3,860 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 842 | $9K |
| 81000 | <1% | 4,163 | $7K | |
| E0570 | Nebulizer, with compressor | <1% | 103 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 438 | $3K |
| 87807 | <1% | 217 | $2K | |
| 99406 | <1% | 605 | $2K | |
| 99188 | <1% | 104 | $757.60 | |
| 81003 | <1% | 31 | $63.86 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 45 | $32.12 |
| 90658 | <1% | 100 | $11.37 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 15 | $7.40 |
| 97802 | <1% | 12 | $5.00 | |
| 90670 | <1% | 3,939 | $0.45 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 43 | $0.20 |
| 90686 | 0% | 963 | $0.00 | |
| 90744 | 0% | 1,160 | $0.00 | |
| 90651 | 0% | 983 | $0.00 | |
| 90680 | 0% | 1,994 | $0.00 | |
| 90698 | 0% | 1,902 | $0.00 | |
| 90696 | 0% | 736 | $0.00 | |
| 90723 | 0% | 990 | $0.00 | |
| 90716 | 0% | 1,371 | $0.00 | |
| 90620 | 0% | 301 | $0.00 | |
| 90619 | 0% | 78 | $0.00 | |
| 90697 | 0% | 39 | $0.00 | |
| 90707 | 0% | 1,387 | $0.00 | |
| 99173 | 0% | 7,476 | $0.00 | |
| 90648 | 0% | 1,737 | $0.00 | |
| 90633 | 0% | 2,270 | $0.00 | |
| 90734 | 0% | 970 | $0.00 | |
| 90715 | 0% | 460 | $0.00 | |
| 90700 | 0% | 964 | $0.00 | |
| 90710 | 0% | 564 | $0.00 | |
| 90685 | 0% | 171 | $0.00 | |
| 90713 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.